Could Red Bull Join The NBA? Austrian Company Circles Sin City Team, New Report Says
Red Bull already owns two Formula 1 teams and Major League Soccer's New York Red Bulls, among other sports-related investments.
Looking Into Carlyle Group’s Recent Short Interest
Carlyle Group’s (NYSE:CG) short percent of float has risen 17.71% since its last report. The company recently reported…
Nvidia-Backed AI Firm CoreWeave Secures $7.5B In Debt Financing: Report
CoreWeave, an AI cloud-computing startup supported by Nvidia, has secured $7.5 billion in debt financing from Blackstone, Carlyle Group, and BlackRock. This funding follows a $1.1 billion equity round, valuing CoreWeave at $19 billion. The funds will expand their data centers and purchase AI chips.
Recap: Carlyle Group Q1 Earnings
Carlyle Group (NASDAQ:CG) reported its Q1 earnings results on Wednesday, May 1, 2024 at 07:00 AM. Here’s what…
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) fell sharply during Wednesday’s session as the company reported first-quarter results…
Looking Into Carlyle Group’s Recent Short Interest
Carlyle Group’s (NYSE:CG) short percent of float has fallen 5.73% since its last report. The company recently reported…
“Carlyle Founders Ordered To Face Lawsuit On $344M Payout” – Bloomberg Law
https://news.bloomberglaw.com/securities-law/carlyle-founders-ordered-to-face-lawsuit-on-344-million-payout Case targets tax buyout related to ‘up-C' corporate structureBillionaire co-founders pushed Carlyle to
(CG) – Analyzing Carlyle Group’s Short Interest
Carlyle Group’s (NYSE:CG) short percent of float has fallen 3.56% since its last report. The company recently reported…
Tian Tu plunges into the red on sagging Hong Kong stock market
Key Takeaways:
Tian Tu Capital posted an 873 million yuan net loss last year, reversing a 559 million yuan profit in 2022
The venture capital firm is getting hit by weakness in the Hong Kong IPO market, one of its primary venues for disposing of its consumer-related investments
By Doug Young
Clinical Collaboration Agreement between Teva And Launch Therapeutics To Accelerate Development Of Dual-Action Asthma Rescue Inhaler Respiratory Program; Teva And Abingworth Enter Strategic Development Funding Agreement To Provide Up To $150M To Offse…
Collaboration combines Teva's expertise in respiratory technology development and Launch Therapeutics' innovative late-stage drug development model to progress Teva's Dual-Action Asthma Rescue Inhaler (TEV-‘248)